Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-mini-MCOP in Elderly DLBCL
NCT06921044Phase 2Not yet recruiting
- Start
- Apr 2025
- Primary completion
- Feb 2026
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
01
Overview
A Phase 2 trial of mitoxantrone-liposome in diffuse large B-cell lymphoma (DLBCL). Planned start Apr 2025; status: not yet recruiting.
02
Drugs
mitoxantrone-liposome
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT06921044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06921044.